Sytuacja epilepsji w Demokratycznej Republice Konga: przegląd badań
Epilepsy landscape in the Democratic Republic of Congo: A narrative review
W skrócie
Epilepsja jest poważnym problemem zdrowia publicznego w Demokratycznej Republice Konga, szczególnie dotykając ludzi młodych w warunkach ograniczonych zasobów. Szacuje się, że od 700 do 1,9 miliona osób żyje z epilepsją, a główne przyczyny to powikłania poporodowe, infekcje mózgu, szczególnie malaria mózgowa i świnka neurycerykoza, oraz urazy głowy. Mimo to 75-80% chorych nie ma dostępu do leczenia z powodu braku lekarzy, stigmy społecznej i niedoboru leków przeciwpadaczkowych.
Oryginalny abstract (angielski)
Epilepsy is a major public health problem in the Democratic Republic of Congo (DRC), disproportionately affecting a young population in a context of limited resources. In this narrative review, we synthesise available epilepsy data from the DRC published between 1990 and 2025. No nationwide, population-based study has been conducted, and existing data come from heterogeneous sources, mostly hospital-based or small regional surveys. The overall epilepsy prevalence is estimated to be between 0.7 % and 1.8 % nationally, representing approximately 700,000 to 1,900,000 people living with epilepsy in a population of 105-109 million. The predominant epilepsy risk factors for epilepsy in DRC include perinatal encephalopathies, central nervous system infections, particularly cerebral malaria, neurocysticercosis, onchocerciasis, meningitis, and traumatic brain injuries. Recent clinic-based data suggest that the average age of seizure onset is 13.1 years +/- 11.2 years, with a wide range spanning from 5 days, and male-to-female ratios ranging from 1.1 to 1.9. Convulsive seizures dominate the clinical picture in the available series. The therapeutic gap remains considerable, with an estimated 75-80 % of people with epilepsy lacking access to appropriate care, a situation exacerbated by persistent sociocultural stigma, a shortage of neurologists (10 per 109 million inhabitants), and the scarcity of diagnostic and monitoring facilities. These findings underscore the urgent need for national management strategies that integrate prevention of avoidable causes, decentralised diagnostic services, improved access to antiseizure medication, and sustained community awareness campaigns.